Abstract
IntroductionIn mechanical thrombectomy (MT) candidates, tenecteplase (TNK) has shown improved reperfusion and outcomes. Therefore, in October of 2020, we transitioned to TNK as the primary thrombolytic for patients presenting with...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have